These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 22584319

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Thymoma and thymic carcinoma: therapeutic approaches.
    Kurup A, Loehrer PJ.
    Clin Lung Cancer; 2004 Jul; 6(1):28-32. PubMed ID: 15310414
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Paclitaxel and cisplatin with concurrent radiotherapy followed by surgery in locally advanced thymic carcinoma.
    Fukuda M, Obase Y, Miyashita N, Kobashi Y, Mohri K, Ueno S, Hayama M, Shimizu K, Nishimura H, Nakata M, Oka M.
    Anticancer Res; 2007 Jul; 27(3B):1601-4. PubMed ID: 17595782
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Response to cytotoxic chemotherapy in patients previously treated with palliative-intent chemotherapy for advanced thymic carcinoma.
    Okuma Y, Hosomi Y, Takahashi S, Maeda Y, Okamura T, Hishima T.
    Clin Lung Cancer; 2015 May; 16(3):221-7. PubMed ID: 25468802
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Systemic treatments for thymoma and thymic carcinoma: A systematic review.
    Berghmans T, Durieux V, Holbrechts S, Jungels C, Lafitte JJ, Meert AP, Moretti L, Ocak S, Roelandts M, Girard N.
    Lung Cancer; 2018 Dec; 126():25-31. PubMed ID: 30527189
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Chemotherapy and targeted agents for thymic malignancies.
    Girard N.
    Expert Rev Anticancer Ther; 2012 May; 12(5):685-95. PubMed ID: 22594902
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Chemotherapy for thymic carcinoma and advanced thymoma in adults.
    Wei ML, Kang D, Gu L, Qiu M, Zhengyin L, Mu Y.
    Cochrane Database Syst Rev; 2013 Aug 23; 2013(8):CD008588. PubMed ID: 23970462
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Amrubicin as second-line and beyond treatment for platinum-refractory advanced thymic carcinoma.
    Hirai F, Seto T, Yamanaka T, Toyozawa R, Inamasu E, Kojo M, Toyokawa G, Morodomi Y, Shiraishi Y, Takenaka T, Yamaguchi M, Takenoyama M, Ichinose Y.
    Jpn J Clin Oncol; 2013 Oct 23; 43(10):1018-22. PubMed ID: 23917962
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.